The Cancer and Chronic Disease Prevention Bureau (CCDPB) develops, implements, and evaluates programs and policies aimed at preventing and controlling the leading causes of death in the District of Columbia. The Cancer Programs Division, within the CCDPB, implements cancer control and prevention initiatives to decrease the morbidities and mortality caused by cancer and eliminates disparities in cancer health outcomes among District residents. Its programs target treatable or preventable cancers, such as breast, cervical, lung, and colorectal through primary and secondary prevention, and are grounded in DC Department of Health’s priority areas: Promoting a culture of health and wellness; Addressing the social determinants of health; Strengthening public-private partnerships; Closing the chasm between clinical medicine and public health; and Implementing data driven and outcome-oriented approaches to program and policy development.
DC Health seeks continued support for three cancer programs; The Breast and Cervical Cancer Early Detection Program (Project WISH), the Comprehensive Cancer Control Program (CCCP), and the DC Cancer Registry (DCCR), that each work seamlessly to build upon past successes and engage in new initiatives to reduce the cancer burden of District residents, specifically targeting at risk populations.
• Project WISH aims to decrease breast and cervical cancer incidence, morbidity, and mortality among low-income, uninsured, and racial/ethnic minority women by facilitating timely access to screening, diagnostic, treatment, and patient navigation services.
• The Comprehensive Cancer Control Program (CCCP) aims to reduce the District’s burden of cancer by using a collaborative process, bringing together the expertise and resources necessary to execute strategies focused on prevention, early detection, and survivorship.
• The DC Cancer Registry (DCCR) is a central cancer registry and population-based incidence cancer data system designed to track trends in cancer incidence, identify differences in cancer incidence by key indicators, determine geographical differences in cancer burden, and generate evidence to inform targeted program strategies.
In addition, the cancer programs will continue to engage community partners to inform and guide its work, including the DC Cancer Coalition, the DC Cancer Registry Advisory Board, and the City-wide Chronic Disease Collaborative. All activities will be managed with input from the DC Cancer Leadership Team, that is comprised of Program Managers from each cancer program, the cancer epidemiologist, and the cancer program evaluator. DC Health looks forward to continuing its partnership with the Centers for Disease Control and Prevention to advance its efforts to reduce the burden of cancer and improve cancer outcomes of District residents.